Trofinetide: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Trofinetide. Educational only — not medical advice.
Labeled uses
DAYBUE and DAYBUE STIX are indicated for the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older.
Source: FDA labeling via NIH DailyMed (set 67e6f2d9…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.